ARTICLE | Company News
Texas Biotech deal
June 7, 1993 7:00 AM UTC
Texas Biotechnology Corp. Texas Biotechnology Corp. has sublicensed Argatroban, a synthetic antithrombolitic derived from L-arginine, from Genentech Inc. (GNE). GNE had licensed the compound from M...